BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Li D, Yang Z, Dai W, Feng X, Liu Y, Jiang Y, Li P, Li Y, Tang B, Zhou Q, Qiu C, Zhang C, Xu X, Feng S, Wang D, Wang H, Wang W, Zheng Y, Zhang L, Wang W, Zhou K, Li S, Yu P. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families. Gut Microbes 2020;11:918-29. [PMID: 31971861 DOI: 10.1080/19490976.2020.1712986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Z, Wang Y, Ji R, Zhang D, Ma C, Ma W, Ma Y, Jiang X, Du K, Zhang R, Chen P. Vanillin Derivatives Reverse Fusobacterium nucleatum-Induced Proliferation and Migration of Colorectal Cancer Through E-Cadherin/β-Catenin Pathway. Front Pharmacol 2022;13:841918. [DOI: 10.3389/fphar.2022.841918] [Reference Citation Analysis]
2 Mori G, Pasca MR. Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer. Int J Mol Sci 2021;22:1312. [PMID: 33525662 DOI: 10.3390/ijms22031312] [Reference Citation Analysis]
3 Chan SCH, Liang JQ. Advances in tests for colorectal cancer screening and diagnosis. Expert Rev Mol Diagn 2022. [PMID: 35400293 DOI: 10.1080/14737159.2022.2065197] [Reference Citation Analysis]
4 Olovo CV, Huang X, Zheng X, Xu M. Faecal microbial biomarkers in early diagnosis of colorectal cancer. J Cell Mol Med 2021. [PMID: 34750964 DOI: 10.1111/jcmm.17010] [Reference Citation Analysis]
5 Stott KJ, Phillips B, Parry L, May S. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer. Biosci Rep 2021:BSR20204113. [PMID: 34236075 DOI: 10.1042/BSR20204113] [Reference Citation Analysis]
6 Zhu Q, Hou Q, Huang S, Ou Q, Huo D, Vázquez-Baeza Y, Cen C, Cantu V, Estaki M, Chang H, Belda-Ferre P, Kim HC, Chen K, Knight R, Zhang J. Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers. ISME J 2021. [PMID: 34079079 DOI: 10.1038/s41396-021-01016-7] [Reference Citation Analysis]
7 Alorda-clara M, Torrens-mas M, Morla-barcelo PM, Martinez-bernabe T, Sastre-serra J, Roca P, Pons DG, Oliver J, Reyes J. Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers. Cancers 2022;14:817. [DOI: 10.3390/cancers14030817] [Reference Citation Analysis]
8 Mo S, Ru H, Huang M, Cheng L, Mo X, Yan L. Oral-Intestinal Microbiota in Colorectal Cancer: Inflammation and Immunosuppression. JIR 2022;Volume 15:747-59. [DOI: 10.2147/jir.s344321] [Reference Citation Analysis]
9 Ma C, Chen K, Wang Y, Cen C, Zhai Q, Zhang J. Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers. Gut Microbes 2021;13:1-6. [PMID: 33430705 DOI: 10.1080/19490976.2020.1869505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shi W, Shen L, Zou W, Wang J, Yang J, Wang Y, Liu B, Xie L, Zhu J, Zhang Z. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study. Front Cell Infect Microbiol 2020;10:562463. [PMID: 33363048 DOI: 10.3389/fcimb.2020.562463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhou H, Yuan Y, Wang H, Xiang W, Li S, Zheng H, Wen Y, Ming Y, Chen L, Zhou J. Gut Microbiota: A Potential Target for Cancer Interventions. Cancer Manag Res 2021;13:8281-96. [PMID: 34764691 DOI: 10.2147/CMAR.S328249] [Reference Citation Analysis]
12 Zhou Z, Ge S, Li Y, Ma W, Liu Y, Hu S, Zhang R, Ma Y, Du K, Syed A, Chen P. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer. Front Microbiol 2020;11:596027. [PMID: 33329482 DOI: 10.3389/fmicb.2020.596027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen J, Wang S, Shen J, Hu Q, Zhang Y, Ma D, Chai K. Analysis of Gut Microbiota Composition in Lung Adenocarcinoma Patients with TCM Qi-Yin Deficiency. Am J Chin Med 2021;49:1667-82. [PMID: 34488552 DOI: 10.1142/S0192415X21500786] [Reference Citation Analysis]